Table II.
Hazard Ratio and 95% Confidence Interval for Study Endpoints by Quartile of D-Dimer, MESA, 2000–2006
D-dimer Quartiles | ||||
---|---|---|---|---|
Outcome Model |
≤0.13 µg/mL | 0,13 – 0.20 µg/mL |
0.21 – 0.37 µg/mL |
>0.37µg/mL |
Total CVD | ||||
Events | 56 | 51 | 98 | 102 |
Person-years | 8516 | 6230 | 7251 | 6804 |
Crude | 1.00 (Reference) |
1.25 (0.85–1.83) |
2.07 (1.49–2.87) |
2.29 (1.66–3.18) |
Age, Sex and Race adjusted | 1.00 (Reference) |
1.01 (0.69–1.49) |
1.41 (1.00–2.00) |
1.29 (0.90–1.85) |
Age, Sex, Race and risk factor* adjusted | 1.00 (Reference) |
0.92 (0.62–1.35) |
1.30 (0.92–1.84) |
1.08 (0.75–1.55) |
Also adjusted for IL–6, Fibrinogen, and CRP |
1.00 (Reference) |
0.87 (0.59–1.28) |
1.20 (0.84–1.70) |
0.95 (0.65–1.39) |
Hard CHD | ||||
Events | 32 | 36 | 68 | 71 |
Person-years | 8575 | 6267 | 7329 | 6866 |
Crude | 1.00 (Reference) |
1.55 (0.96–2.49) |
2.51 (1.65–3.82) |
2.80 (1.84–4.25) |
Age, Sex and Race adjusted | 1.00 (Reference) |
1.24 (0.76–2.00) |
1.69 (1.09–2.62) |
1.55 (0.98–2.44) |
Age, Sex, Race and risk factor* adjusted |
1.00 (Reference) |
1.11 (0.69–1.81) |
1.53 (0.98–2.38) |
1.27 (0.80–2.01) |
Also adjusted for IL–6, Fibrinogen, and CRP |
1.00 (Reference) |
1.05 (0.64–1.71) |
1.41 (0.90–2.21) |
1.11 (0.69–1.79) |
Total Mortality | ||||
Events | 21 | 34 | 58 | 97 |
Person-years | 8796 | 6479 | 7533 | 7124 |
Crude | 1.00 (Reference) |
2.21 (1.28–3.30) |
3.26 (1.98–5.37) |
5.79 (3.61–9.28) |
Age, Sex and Race adjusted | 1.00 (Reference) |
1.69 (0.97–2.92) |
1.98 (1.18–3.31) |
2.75 (1.66–4.55) |
Age, Sex, Race and risk factor* adjusted |
1.00 (Reference) |
1.62 (0.94–2.81) |
1.91 (1.14–3.21) |
2.57 (1.54–4.27) |
Also adjusted for IL–6, Fibrinogen, and CRP |
1.00 (Reference) |
1.48 (0.85–2.58) |
1.70 (1.00–2.87) |
2.14 (1.27–3.61) |
Body mass index, systolic blood pressure, antihypertensive medications, LDL and HDL cholesterol, statin use, usual alcohol intake, smoking status, cigarette pack-years, exercise, and glycemia status.